ClinicalTrials.gg
RecruitingNCT07734844ALTOUpdated Nov 3, 2026

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

A Phase 3 interventional study of Tabirafusp tedromer and Aflibercept (2.0 mg) in Diabetic Macular Edema (DME), sponsored by Kodiak Sciences Inc. Recruiting at 52 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Kodiak Sciences Inc · Phase 3, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Aug 2026; still recruiting 3 months later.
Updated Nov 3, 2026First site in Argentina43 sites addedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 3
Study type
Interventional
Enrollment
910
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 276 studies in Macular Edema with a site in United States — 16 open to participants now, 32 under way, 11 of them phase 3. Macular Edema · United States.

Planned enrollment
11th of 244
910 · median 45
Started
2026
with 9 others
Phase 3
50 of 276
5 open now
Primary completion
2028-08
later than 27 of 31 live
Registered
274th of 276
by date
Lead sponsor
6 of 276
Kodiak Sciences Inc

Among the 276 studies in Macular Edema with a site in United States, this one is the 11th largest by planned enrollment of the 244 interventional ones that give a count, is one of 10 that started in 2026, is one of 50 in phase 3, reaches primary completion later than 27 of the 31 other live ones, and was the 274th registered.

Macular Edema

759 studies on the registry are indexed under Macular Edema; 66 are open to participants now.

Browse Macular Edema studies →

Open to participants now

16 of the 276 studies in Macular Edema with a site in United States are open now. Recruiting first, the newest first:

10 more — sign in →

All 16 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 43 Macular Edema studies recruiting now, 31 (72%) set no upper age limit and 7 (16%) stop at 75 or younger; 1 takes children under 18; 2 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 276 studies in Macular Edema with a site in United States, or all of them as a file.
02

Study summary

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants with Diabetic Macular Edema - ALTO

03

Conditions studied

  • Diabetic Macular Edema (DME)

Browse trials for

Keywords

  • DME
  • KSI-501
  • tabirafusp tedromer
  • aflibercept
  • antibody biopolymer conjugate
  • anti-VEGF
  • anti-IL-6
  • Kodiak Sciences
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • DME, treatment-naïve or previously-treated
  • Male or female ≥18 years of age with Type 1 or Type 2 diabetes mellitus and a of ≤12%
  • Capable of giving informed signed consent

Exclusion criteria

Exclusion Criteria:

  • Active iris or angle neovascularization or neovascular glaucoma in the Study Eye.
  • Current or history of retinal detachment (tractional or rhegmatogenous) in the Study Eye
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
910 participants (estimated)

Study arms

  • Experimental
    Tabirafusp tedromer 5 mg Q8W

    Intravitreal injection of tabirafusp tedromer once every 4 weeks for 6 monthly doses followed by every-8-week dosing with additional individualized dosing (up to monthly dosing)

    Drug: Tabirafusp tedromer

  • Experimental
    Tabirafusp tedromer 5 mg Q4-24W

    Intravitreal injection of tabirafusp tedromer once every 4 weeks for 6 monthly doses followed by individualized dosing every 4 to 24 weeks.

    Drug: Tabirafusp tedromer

  • Active comparator
    Aflibercept 2 mg

    Intravitreal injection of aflibercept once every 4 weeks for 5 monthly doses followed by every-8-week dosing

    Drug: Aflibercept (2.0 mg)

Interventions

  • DrugTabirafusp tedromer

    Intravitreal injection

    Also known as: KSI-501

  • DrugAfliberceptStudies of AfliberceptAflibercept pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Intravitreal injection

    Also known as: Eylea

06

What researchers measure

Primary outcomes

  1. Best corrected visual acuity (BCVA)

    Mean change in BCVA from Day 1 to Year 1

    Time frame: Week 52

07

Study locations

52 of 52 sites recruiting
  • Kodiak Research Center
    Scottsdale, Arizona 85255, United States
    Recruiting
  • Kodiak Research Center
    Bakersfield, California 93309, United States
    Recruiting
  • Kodiak Research Center
    Glendale, California 91204, United States
    Recruiting
  • Kodiak Research Center
    Modesto, California 95356, United States
    Recruiting
  • Kodiak Research Center
    Oxnard, California 93036, United States
    Recruiting
  • Kodiak Research Center
    Pasadena, California 91107, United States
    Recruiting
  • Kodiak Research Center
    Redlands, California 92373, United States
    Recruiting
  • Kodiak Research Center
    Redlands, California 92374, United States
    Recruiting
  • Kodiak Research Center
    Sacramento, California 95825, United States
    Recruiting
  • Kodiak Research Center
    Sacramento, California 95841, United States
    Recruiting
  • Kodiak Research Center
    Waterford, Connecticut 06385, United States
    Recruiting
  • Kodiak Research Center
    Fort Lauderdale, Florida 33308, United States
    Recruiting
  • Kodiak Research Center
    St. Petersburg, Florida 33711, United States
    Recruiting
  • Kodiak Research Center
    Winter Haven, Florida 33880, United States
    Recruiting
  • Kodiak Research Center
    Elmhurst, Illinois 60126, United States
    Recruiting
  • Kodiak Research Center
    Hagerstown, Maryland 21740, United States
    Recruiting
  • Kodiak Research Center
    Saint Louis Park, Minnesota 55416, United States
    Recruiting
  • Kodiak Research Center
    Madison, Mississippi 39110, United States
    Recruiting
  • Kodiak Research Center
    Hauppauge, New York 11788, United States
    Recruiting
  • Kodiak Research Center
    Rochester, New York 14620, United States
    Recruiting
  • Kodiak Research Center
    Cary, North Carolina 27511, United States
    Recruiting
  • Kodiak Research Center
    Greensboro, North Carolina 27401, United States
    Recruiting
  • Kodiak Research Center
    Hickory, North Carolina 28602, United States
    Recruiting
  • Kodiak Research Center
    Wake Forest, North Carolina 27587, United States
    Recruiting
  • Kodiak Research Center
    Winston-Salem, North Carolina 27587, United States
    Recruiting
  • Kodiak Research Center
    Beaufort, South Carolina 29902, United States
    Recruiting
  • Kodiak Research Center
    Charleston, South Carolina 29414, United States
    Recruiting
  • Kodiak Research Center
    Ladson, South Carolina 29456, United States
    Recruiting
  • Kodiak Research Center
    Mt. Pleasant, South Carolina 29464, United States
    Recruiting
  • Kodiak Research Center
    West Columbia, South Carolina 29169, United States
    Recruiting
  • Kodiak Research Center
    Sioux Falls, South Dakota 57108, United States
    Recruiting
  • Kodiak Research Center
    Amarillo, Texas 79106, United States
    Recruiting
  • Kodiak Research Center
    Arlington, Texas 76012, United States
    Recruiting
  • Kodiak Research Center
    Austin, Texas 78705, United States
    Recruiting
  • Kodiak Research Center
    Bellaire, Texas 77401, United States
    Recruiting
  • Kodiak Research Center
    Fort Worth, Texas 76104, United States
    Recruiting
  • Kodiak Research Center
    Katy, Texas 77494, United States
    Recruiting
  • Kodiak Research Center
    Plano, Texas 75075, United States
    Recruiting
  • Kodiak Research Center
    Round Rock, Texas 78681, United States
    Recruiting
  • Kodiak Research Center
    San Antonio, Texas 78240, United States
    Recruiting
  • Kodiak Research Center
    Schertz, Texas 78154, United States
    Recruiting
  • Kodiak Research Center
    The Woodlands, Texas 77384, United States
    Recruiting
  • Kodiak Research Center
    Lynchburg, Virginia 24502, United States
    Recruiting
  • Kodiak Research Center
    Bellevue, Washington 98004, United States
    Recruiting
  • Kodiak Research Center
    Caba, Buenos Aires 1015, Argentina
    Recruiting
  • Kodiak Research Center
    Caba, Buenos Aires C1023AAQ, Argentina
    Recruiting
  • Kodiak Research Center
    Caba, Buenos Aires C1061, Argentina
    Recruiting
  • Kodiak Research Center
    Caba, Buenos Aires C1121ABB, Argentina
    Recruiting
  • Kodiak Research Center
    Comodoro Rivadavia, Chubut Province 9000, Argentina
    Recruiting
  • Kodiak Research Center
    Mendoza, Mendoza Province 5500, Argentina
    Recruiting
  • Kodiak Research Center
    Rosario, Santa Fe Province 2000, Argentina
    Recruiting
  • Kodiak Research Center
    Rosario, Santa Fe Province S2000DSK, Argentina
    Recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Aug 2028, 24 months after the start.

Of 52 industry-sponsored phase 3 interventional studies under Macular Edema, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 33. This study's planned 24 months is close to that.

Counting every sponsor, half of 65 studies reached it within 25 months; a quarter within 18 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
May 30, 2026
First posted
Jul 29, 2026
StartActual
Aug 3, 2026
Primary completionEst.
Aug 31, 2028
CompletionEst.
Sep 2029
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
43 sites added — first site in Argentina
Show 43 added (35 United States, 8 Argentina)
  • Kodiak Research Center · Scottsdale, United States
  • Kodiak Research Center · Bakersfield, United States
  • Kodiak Research Center · Modesto, United States
  • Kodiak Research Center · Oxnard, United States
  • Kodiak Research Center · Redlands, United States
  • Kodiak Research Center · Redlands, United States
  • Kodiak Research Center · Sacramento, United States
  • Kodiak Research Center · Sacramento, United States
  • Kodiak Research Center · Waterford, United States
  • Kodiak Research Center · Fort Lauderdale, United States
  • Kodiak Research Center · Winter Haven, United States
  • Kodiak Research Center · Elmhurst, United States
  • Kodiak Research Center · Madison, United States
  • Kodiak Research Center · Hauppauge, United States
  • Kodiak Research Center · Rochester, United States
  • Kodiak Research Center · Cary, United States
  • Kodiak Research Center · Greensboro, United States
  • Kodiak Research Center · Hickory, United States
  • Kodiak Research Center · Wake Forest, United States
  • Kodiak Research Center · Winston-Salem, United States
  • Kodiak Research Center · Mt. Pleasant, United States
  • Kodiak Research Center · Sioux Falls, United States
  • Kodiak Research Center · Amarillo, United States
  • Kodiak Research Center · Arlington, United States
  • Kodiak Research Center · Austin, United States
  • Kodiak Research Center · Bellaire, United States
  • Kodiak Research Center · Fort Worth, United States
  • Kodiak Research Center · Katy, United States
  • Kodiak Research Center · Plano, United States
  • Kodiak Research Center · Round Rock, United States
  • …and 13 more on the registry record
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    43 sites added — first site in Argentina
    Show 43 added (35 United States, 8 Argentina)
    • Kodiak Research Center · Scottsdale, United States
    • Kodiak Research Center · Bakersfield, United States
    • Kodiak Research Center · Modesto, United States
    • Kodiak Research Center · Oxnard, United States
    • Kodiak Research Center · Redlands, United States
    • Kodiak Research Center · Redlands, United States
    • Kodiak Research Center · Sacramento, United States
    • Kodiak Research Center · Sacramento, United States
    • Kodiak Research Center · Waterford, United States
    • Kodiak Research Center · Fort Lauderdale, United States
    • Kodiak Research Center · Winter Haven, United States
    • Kodiak Research Center · Elmhurst, United States
    • Kodiak Research Center · Madison, United States
    • Kodiak Research Center · Hauppauge, United States
    • Kodiak Research Center · Rochester, United States
    • Kodiak Research Center · Cary, United States
    • Kodiak Research Center · Greensboro, United States
    • Kodiak Research Center · Hickory, United States
    • Kodiak Research Center · Wake Forest, United States
    • Kodiak Research Center · Winston-Salem, United States
    • Kodiak Research Center · Mt. Pleasant, United States
    • Kodiak Research Center · Sioux Falls, United States
    • Kodiak Research Center · Amarillo, United States
    • Kodiak Research Center · Arlington, United States
    • Kodiak Research Center · Austin, United States
    • Kodiak Research Center · Bellaire, United States
    • Kodiak Research Center · Fort Worth, United States
    • Kodiak Research Center · Katy, United States
    • Kodiak Research Center · Plano, United States
    • Kodiak Research Center · Round Rock, United States
    • …and 13 more on the registry record

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07734844
Lead sponsor
Kodiak Sciences Inc
Responsible party
Sponsor
First posted
Jul 29, 2026
Start date
Aug 3, 2026
Primary completion
Aug 31, 2028 (estimated)
Completion
Sep 2029 (estimated)
Last update
Nov 3, 2026

Study contacts

Kodiak Sciences Inc
Contact
ClinicalTrials@kodiak.com
6502810850
J. Pablo Velazquez-Martin, MD
study director · Kodiak Sciences Inc

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion